Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | phosphorylation at the activation loop residue Y185 by MKK4 activates JNK | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of wild-type and mutant enzymes with or without His6-tag in Escherichia coli strain BL21(DE3) | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
purified recombinant His-tagged mutant enzyme in complex with inhibitor furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide in 0.1 M MES, pH5.6, and 0.88 M sodium citrate, mixing of 0.001 ml of protein in 50 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM MgCl2, 5% glycerol, 5 mM DTT, and 0.02% octyl-beta-D-glucopyranoside with 0.001 ml of 0.1 M MES, pH 5.6, 0.56-0.62 M sodium citrate, and 500 nl of 1000fold diluted seed stock, X-ray diffraction structure determination and analysis at 2.15 A resolution, molecular replacment and modelling | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
C177S/C222S/K250A/K251A/K265A/K270A | site-directed mutagenesis, the hexa-surfaced mutant forms crystallization complexes with inhibitor furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide in contrast to other mutant variants or the wild-type enzyme | Homo sapiens |
D3K/C6V/S8N/14E | site-directed mutagenesis using JNK2 1-362 or 1-364, the mutant does not crystallize | Homo sapiens |
K203A/E204A | site-directed mutagenesis, the mutant does not crystallize | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide | inhibits JNK2alpha2 enzyme in vitro | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | JNK2 shows conformational flexibility in the MAP kinase insert and its involvement in the regulation of catalytic activity, the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners, overview | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P45984 | JNK2 | - |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | phosphorylation ate the activation loop residue Y185 by MKK4 activates JNK | Homo sapiens |
Purification (Comment) | Organism |
---|---|
recombinant wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by anion exchange chromatography and gel filtration for non-tagged proteins, His6-tagged proteins are purified by nickel affinity chromatography | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | JNK2 shows conformational flexibility in the MAP kinase insert and its involvement in the regulation of catalytic activity, the MAP kinase insert of JNK2 plays a role in the regulation of JNK2 activation, possibly by interacting with intracellular binding partners, overview | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | structure analysis of JNK2, conformational flexibility of activation loop and loop 14 region, overview | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
c-Jun N-terminal kinase 2 | - |
Homo sapiens |
JNK 2 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00012 | - |
- |
Homo sapiens | furan-2-carboxylic acid (3-[5-(4H-[1,2,4]triazol-3-yl)-1H-indazol-3-yl]-phenyl)-amide |